Skip to content
Riskpilot
← Back to search
Sign in
Get full access
PHARMA 2100 ApS
APS
Bankrupt
Advertising protection
CVR 26382785
Dronning Ingeborgs Vej 9, 4000
Roskilde
Industriel design og produktdesign
·
NACE 741010
Est. 2002 · 24 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Industriel design og produktdesign
/
PHARMA 2100 ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2013
0M
2014
0M
2015
0M
2016
0M
2017
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2013
0M
0%
2014
0M
0%
2015
0M
0%
2016
0M
0%
2017
Income statement
DKK thousands
Item
2013
2014
2015
2016
2017
Revenue
0
0
-2
0
0
Staff expenses
-25
-0
-0
-0
-0
EBITDA
-25
-5
-2
0
-20
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-25
-5
-2
0
-20
Net financials
0
0
0
0
0
Profit before tax
-25
-5
-2
0
-20
Tax
-0
-0
-0
-0
-0
Net profit
-25
-5
-2
0
-20
Balance sheet
DKK thousands
Item
2013
2014
2015
2016
2017
Total assets
83
52
50
50
29
Equity
57
52
50
50
29
Long-term debt
0
0
0
0
0
Short-term debt
25
0
0
0
0
Total debt
25
0
0
0
0
Financial ratios
5-year trend
EBITDA margin
-2045500.0%
This company
15.8%
Market median
-12946303% vs market
2013
2017
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
2013
2017
Return on equity
-69.6%
This company
18.4%
Market median
-478% vs market
2013
2017
Net profit margin
-2045500.0%
This company
8.1%
Market median
-25253186% vs market
2013
2017
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2013
2017
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2013
2017
Annual reports & filings
Annual report 2017
Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
View
PDF
Annual report 2016
Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
View
PDF
Annual report 2015
Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
View
PDF
Annual report 2014
Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
View
PDF
Annual report 2013
Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
View
PDF
More on PHARMA 2100 ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
